Rapid Pathogen Screening, Inc. (RPS®), an emerging leader in point-of-care diagnostic testing, today announced that Douglas W. Berg has been appointed to its Board of Directors, effective...
(PRWeb April 20, 2012)
Read the full story at http://www.prweb.com/releases/2012/4/prweb9423127.htm
A Nevada judge set the first trial date involving Johnson & Johnson subsidiary DePuy Orthopaedics, Inc.’s recalled ASR hip to begin December 3rd. The trial will take place in a Las Vegas, Nevada...
(PRWeb April 20, 2012)
Read the full story at http://www.prweb.com/releases/2012/4/prweb9422152.htm
The ubiquitin-selective chaperone, p97, is emerging as an exciting new therapeutic target for diverse diseases and pathologies, however its low intrinsic ATPase activity has made it difficult to adapt...
(PRWeb April 20, 2012)
Read the full story at http://www.prweb.com/releases/2012/4/prweb9400753.htm
Winners to be Announced at April 25th Awards Ceremony
(PRWeb April 19, 2012)
Read the full story at http://www.prweb.com/releases/2012/4/prweb9420442.htm
Many people are not aware that toxins lurk in every day health and beauty aids. Topical BioMedics is helping consumers honor Earth Day--and themselves--by giving the family medicine cabinet a healthy,...
(PRWeb April 19, 2012)
Read the full story at http://www.prweb.com/releases/2012/4/prweb9418756.htm
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
Recent Comments